NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
204 hedge funds and large institutions have $5.24B invested in NEVRO CORP. in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 82 increasing their positions, 75 reducing their positions, and 47 closing their positions.
78% more call options, than puts
Call options by funds: $21.8M | Put options by funds: $12.2M
9% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 75
10% less funds holding
Funds holding: 226 → 204 (-22)
17% less capital invested
Capital invested by funds: $6.32B → $5.24B (-$1.08B)
43% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 47
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$109M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$89.5M |
| 3 |
Morgan Stanley
New York
|
+$34.5M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$33.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$84.1M |
| 2 |
D.E. Shaw & Co
New York
|
-$55.1M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$50.1M |
| 4 |
TEC
Tiger Eye Capital
Nashville,
Tennessee
|
-$38.5M |
| 5 |
HM
HealthCor Management
New York
|
-$27M |
NVRO Hedge Fund Activity: Q1 2021 in Review
204 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2021, worth a combined $5.24B — down 17% from $6.32B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of NVRO and 27 opened new positions — a net loss of 20 holders — while 75 trimmed existing stakes and 82 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $109M. The largest seller was Lord, Abbett & Co, cutting an estimated $84.1M.
- 204 institutional investors held NEVRO CORP. (NVRO) as of Q1 2021, down from 226 in Q4 2020.
- Funds reported $5.24B of NEVRO CORP. stock for Q1 2021, down 17% quarter-over-quarter.
- 27 funds opened new NEVRO CORP. positions in Q1 2021 and 47 closed out, a net change of -20 holders.
- The largest NEVRO CORP. buyer in Q1 2021 was T. Rowe Price Associates, an estimated $109M added.
- The largest NEVRO CORP. seller in Q1 2021 was Lord, Abbett & Co, an estimated $84.1M sold.
Based on aggregated 13F filings for Q1 2021.